These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16620133)

  • 1. Targeting virulence for antibacterial chemotherapy: identifying and characterising virulence factors for lead discovery.
    Marra A
    Drugs R D; 2006; 7(1):1-16. PubMed ID: 16620133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can virulence factors be viable antibacterial targets?
    Marra A
    Expert Rev Anti Infect Ther; 2004 Feb; 2(1):61-72. PubMed ID: 15482172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.
    Rampioni G; Leoni L; Williams P
    Bioorg Chem; 2014 Aug; 55():60-8. PubMed ID: 24823895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives for a new century: implications of pathogen responses for the future of antimicrobial therapy.
    Melstrom KA; Smith JW; Gamelli RL; Shankar R
    J Burn Care Res; 2006; 27(3):251-64. PubMed ID: 16679890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y; Eguchi Y; Watanabe T; Okamoto S; Doi A; Utsumi R
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-virulence Strategies to Target Bacterial Infections.
    Mühlen S; Dersch P
    Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of quorum sensing-controlled virulence factors by Nymphaea tetragona (water lily) extract.
    Hossain MA; Lee SJ; Park JY; Reza MA; Kim TH; Lee KJ; Suh JW; Park SC
    J Ethnopharmacol; 2015 Nov; 174():482-91. PubMed ID: 26325430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New screens and targets in antibacterial drug discovery.
    Falconer SB; Brown ED
    Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial virulence as a target for antimicrobial chemotherapy.
    Alksne LE; Projan SJ
    Curr Opin Biotechnol; 2000 Dec; 11(6):625-36. PubMed ID: 11102800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Block Bacterial Pathogenesis by Interference with Motility and Chemotaxis.
    Erhardt M
    Curr Top Microbiol Immunol; 2016; 398():185-205. PubMed ID: 27000091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting virulence: a new paradigm for antimicrobial therapy.
    Clatworthy AE; Pierson E; Hung DT
    Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of new antibacterial drugs that target bacterial quorum sensing systems].
    Yin SL; Chang YJ; Deng SP; Wang QC; Yu WG; Gong QH
    Yao Xue Xue Bao; 2011 Jun; 46(6):613-21. PubMed ID: 21882519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs].
    Gintsburg AL; Zigangirova NA; Zorina VV
    Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?
    Otto M
    FEMS Microbiol Lett; 2004 Dec; 241(2):135-41. PubMed ID: 15598524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The search for novel antibiotics--strategies and current approaches].
    Schmid P
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):498-512. PubMed ID: 25872259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirulence as a new antibacterial approach for chemotherapy.
    Escaich S
    Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.